1	Paciente	paciente	NCCS000	C0030705	persona	0-8	745_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	9-11	745_QUEST_clinical_caseMIR	SENT1	-	-
3	65	65		-	-	12-14	745_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	15-19	745_QUEST_clinical_caseMIR	SENT1	-	-
5	con	con	SPS00	C0332287	atributo	20-23	745_QUEST_clinical_caseMIR	SENT1	-	-
6	antecedentes	antecedente	NCMP000	C0332119_1	situación_1	24-36	745_QUEST_clinical_caseMIR	SENT1	-	-
7	de	de	SPS00	C0332119_2	situación_2	37-39	745_QUEST_clinical_caseMIR	SENT1	-	-
8	consumo	consumo	NCMS000	-	-	40-47	745_QUEST_clinical_caseMIR	SENT1	-	-
9	habitual	habitual	AQ0CS0	C0205353	calificador	48-56	745_QUEST_clinical_caseMIR	SENT1	-	-
10	de	de	SPS00	C0332285	atributo	57-59	745_QUEST_clinical_caseMIR	SENT1	-	-
11	alcohol	alcohol	NCMS000	C0001975	sustancia	60-67	745_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
12	que	que	PR0CN000	-	-	68-71	745_QUEST_clinical_caseMIR	SENT1	-	-
13	es	ser	VSIP3S0	-	-	72-74	745_QUEST_clinical_caseMIR	SENT1	-	-
14	atendido	atender	VMP00SM	-	-	75-83	745_QUEST_clinical_caseMIR	SENT1	-	-
15	en	en	SPS00	C1720294#C0332285	calificador#atributo	84-86	745_QUEST_clinical_caseMIR	SENT1	-	-
16	urgencias	urgencia	NCFP000	C0439609	calificador	87-96	745_QUEST_clinical_caseMIR	SENT1	-	-
17	por	por	SPS00	C0678226	atributo	97-100	745_QUEST_clinical_caseMIR	SENT1	-	-
18	cuadro	cuadro	NCMS000	-	-	101-107	745_QUEST_clinical_caseMIR	SENT1	-	-
19	clínico	clínico	AQ0MS0	C0205210	calificador	108-115	745_QUEST_clinical_caseMIR	SENT1	-	-
20	de	de	SPS00	C0332285	atributo	116-118	745_QUEST_clinical_caseMIR	SENT1	-	-
21	24	24	Z	C0439584_1	calificador_1	119-121	745_QUEST_clinical_caseMIR	SENT1	-	-
22	horas	hora	NCFP000	C0439584_2	calificador_2	122-127	745_QUEST_clinical_caseMIR	SENT1	-	-
23	de	de	SPS00	C0332285	atributo	128-130	745_QUEST_clinical_caseMIR	SENT1	-	-
24	evolución	evolución	NCFS000	-	-	131-140	745_QUEST_clinical_caseMIR	SENT1	-	-
25	de	de	SPS00	C0332285	atributo	141-143	745_QUEST_clinical_caseMIR	SENT1	-	-
26	fiebre	fiebre	NCFS000	C0015967	hallazgo	144-150	745_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
27	,	,	Fc	-	-	150-151	745_QUEST_clinical_caseMIR	SENT1	-	-
28	cefalea	cefalea	NCFS000	C0018681	hallazgo	152-159	745_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
29	,	,	Fc	-	-	159-160	745_QUEST_clinical_caseMIR	SENT1	-	-
30	rigidez	rigidez	NCFS000	C1320474#C0151315_1	hallazgo_1	161-168	745_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
31	de	de	SPS00	C1320474#C0151315_2	hallazgo_2	169-171	745_QUEST_clinical_caseMIR	SENT1	-	-
32	nuca	nuca	NCFS000	C1320474#C0151315_3	hallazgo_3	172-176	745_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
33	y	y	CC	C1706368	calificador	177-178	745_QUEST_clinical_caseMIR	SENT1	-	-
34	progresivo	progresivo	AQ0MS0	C0205329	calificador	179-189	745_QUEST_clinical_caseMIR	SENT1	-	-
35	deterioro	deterioro	NCMS000	C1265875#C0684336#C0231171	anomalía_morfológica#hallazgo	190-199	745_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
36	del	del	SP+DA	-	-	200-203	745_QUEST_clinical_caseMIR	SENT1	-	-
37	nivel	nivel	NCMS000	C0234425_1	entidad_observable_1	204-209	745_QUEST_clinical_caseMIR	SENT1	-	-
38	de	de	SPS00	C0234425_2	entidad_observable_2	210-212	745_QUEST_clinical_caseMIR	SENT1	-	-
39	conciencia	concienciar	VMM02S0	C0234425_3	entidad_observable_3	213-223	745_QUEST_clinical_caseMIR	SENT1	-	-
40	.	.	Fp	-	-	223-224	745_QUEST_clinical_caseMIR	SENT1	-	-

1	Se	se	P00CN000	-	-	225-227	745_QUEST_clinical_caseMIR	SENT2	-	-
2	realiza	realizar	VMIP3S0	-	-	228-235	745_QUEST_clinical_caseMIR	SENT2	-	-
3	una	una		C0205447_1	calificador_1	236-239	745_QUEST_clinical_caseMIR	SENT2	-	-
4	TC	símbolo_químico_del_tecnecio	NC00YL0	-	-	240-242	745_QUEST_clinical_caseMIR	SENT2	-	-
5	craneal	craneal	AQ0CS0	C0205096#C3163631	calificador	243-250	745_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
6	que	que	PR0CN000	-	-	251-254	745_QUEST_clinical_caseMIR	SENT2	-	-
7	es	ser	VSIP3S0	-	-	255-257	745_QUEST_clinical_caseMIR	SENT2	-	-
8	normal	normal	AQ0CS0	C0205307	calificador	258-264	745_QUEST_clinical_caseMIR	SENT2	-	-
9	y	y	CC	C1706368	calificador	265-266	745_QUEST_clinical_caseMIR	SENT2	-	-
10	seguidamente	seguidamente	RG	-	-	267-279	745_QUEST_clinical_caseMIR	SENT2	-	-
11	una	una		C0205447_1	calificador_1	280-283	745_QUEST_clinical_caseMIR	SENT2	-	-
12	punción	punción	NCFS000	C0037943#C0553794_1	procedimiento_1	284-291	745_QUEST_clinical_caseMIR	SENT2	-	-
13	lumbar	lumbar	NC00SC0	C0037943#C0553794_2	procedimiento_2	292-298	745_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
14	que	que	PR0CN000	-	-	299-302	745_QUEST_clinical_caseMIR	SENT2	-	-
15	muestra	mostrar	VMIP3S0	-	-	303-310	745_QUEST_clinical_caseMIR	SENT2	-	-
16	un	un		C0205447_1	calificador_1	311-313	745_QUEST_clinical_caseMIR	SENT2	-	-
17	LCR	lcr	NC00SC0	C0007806	sustancia	314-317	745_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
18	con	con	SPS00	C0332287	atributo	318-321	745_QUEST_clinical_caseMIR	SENT2	-	-
19	pleocitosis	pleocitosis	NC00SC0	C0151857	hallazgo	322-333	745_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
20	(	(	Fpa	-	-	334-335	745_QUEST_clinical_caseMIR	SENT2	-	-
21	1500	1500		-	-	335-339	745_QUEST_clinical_caseMIR	SENT2	-	-
22	células	célula	NCFP000	C1269647#C0007634	célula#estructura_corporal	340-347	745_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
23	/	/	Fh	-	-	347-348	745_QUEST_clinical_caseMIR	SENT2	-	-
24	μl	μl	NCMS000	-	-	348-350	745_QUEST_clinical_caseMIR	SENT2	-	-
25	)	)	Fpt	-	-	350-351	745_QUEST_clinical_caseMIR	SENT2	-	-
26	,	,	Fc	-	-	351-352	745_QUEST_clinical_caseMIR	SENT2	-	-
27	hiperproteinorraquia	hiperproteinorraquia	NCFS000	-	-	353-373	745_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
28	(	(	Fpa	-	-	374-375	745_QUEST_clinical_caseMIR	SENT2	-	-
29	325	325	Z	-	-	375-378	745_QUEST_clinical_caseMIR	SENT2	-	-
30	mg	mg	NCMN000	-	-	379-381	745_QUEST_clinical_caseMIR	SENT2	-	-
31	/	/	Fh	-	-	381-382	745_QUEST_clinical_caseMIR	SENT2	-	-
32	dl	decilitro	NCMN000	C0439241	calificador	382-384	745_QUEST_clinical_caseMIR	SENT2	-	-
33	)	)	Fpt	-	-	384-385	745_QUEST_clinical_caseMIR	SENT2	-	-
34	e	y	CC	C1706368	calificador	386-387	745_QUEST_clinical_caseMIR	SENT2	-	-
35	hipoglucorraquia	hipoglucorraquia	NCFS000	-	-	388-404	745_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
36	(	(	Fpa	-	-	405-406	745_QUEST_clinical_caseMIR	SENT2	-	-
37	<	<	Fz	-	-	406-407	745_QUEST_clinical_caseMIR	SENT2	-	-
38	10	10	Z	-	-	408-410	745_QUEST_clinical_caseMIR	SENT2	-	-
39	mg	mg	NCMN000	-	-	411-413	745_QUEST_clinical_caseMIR	SENT2	-	-
40	/	/	Fh	-	-	413-414	745_QUEST_clinical_caseMIR	SENT2	-	-
41	dl	decilitro	NCMN000	C0439241	calificador	414-416	745_QUEST_clinical_caseMIR	SENT2	-	-
42	)	)	Fpt	-	-	416-417	745_QUEST_clinical_caseMIR	SENT2	-	-
43	.	.	Fp	-	-	417-418	745_QUEST_clinical_caseMIR	SENT2	-	-

1	El	el	DA0MS0	-	-	419-421	745_QUEST_clinical_caseMIR	SENT3	-	-
2	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	422-433	745_QUEST_clinical_caseMIR	SENT3	-	-
3	antibiótico	antibiótico	AQ0MS0	C0003232	producto#sustancia	434-445	745_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
4	empírico	empírico	NCMS000	-	-	446-454	745_QUEST_clinical_caseMIR	SENT3	-	-
5	inicial	inicial	AQ0CS0	C0205265	calificador	455-462	745_QUEST_clinical_caseMIR	SENT3	-	-
6	más	más	RG	C0205172	calificador	463-466	745_QUEST_clinical_caseMIR	SENT3	-	-
7	correcto	correcto	AQ0MS0	C0205170	calificador	467-475	745_QUEST_clinical_caseMIR	SENT3	-	-
8	de	de	SPS00	C0332285	atributo	476-478	745_QUEST_clinical_caseMIR	SENT3	-	-
9	entre	entre	SPS00	C0205103	calificador	479-484	745_QUEST_clinical_caseMIR	SENT3	-	-
10	los	el	DA0MP0	-	-	485-488	745_QUEST_clinical_caseMIR	SENT3	-	-
11	siguientes	siguiente	AQ0CP0	C0332282	atributo	489-499	745_QUEST_clinical_caseMIR	SENT3	-	-
12	es	ser	VSIP3S0	-	-	500-502	745_QUEST_clinical_caseMIR	SENT3	-	-
13	:	:	Fd	-	-	502-503	745_QUEST_clinical_caseMIR	SENT3	-	-
14	.	.	Fp	-	-	503-504	745_QUEST_clinical_caseMIR	SENT3	-	-

